Tag: deep vein thrombosis

First-in-human study of Pounce thrombectomy system in acute iliofemoral DVT demonstrates...

Twelve-month outcomes from the Pounce venous thrombectomy system (Vetex Medical) first-in-human study evaluating its use in the treatment of acute iliofemoral deep vein thrombosis...

Tackling DVT head on: Single-session, wall-to-wall thrombus removal with the ClotTriever...

This advertorial is sponsored by Inari Medical. Several years ago, when Nicolas Mouawad, MD, division chief of vascular surgery at McLaren Health in Bay City,...
IVC filters

U.S. study highlights racial and ethnic disparities in the placement of...

A nationwide U.S. study, recently published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL), showed that Black patients had the highest...

Mechanical thrombectomy demonstrates superior outcomes to anticoagulation in DVT patients, analysis...

Mechanical thrombectomy using the ClotTriever device (Inari Medical) for iliofemoral deep vein thrombosis (DVT) was found to be “associated with significantly” lower Villalta scores...

Large administrative databases enter crosshairs as comparative analysis shows percutaneous mechanical...

The pitfalls of large administrative databases came to the fore during the presentation of a propensity-match scoring analysis demonstrating that percutaneous mechanical thrombectomy (MT)...

One-year CLOUT data demonstrate low rate of PTS following treatment with...

David Dexter (Sentara Vascular Specialists, Norfolk, USA) shared one-year data from the CLOUT registry this week at The VEINS 2023 (28–30 October, Las Vegas,...
deep vein thrombosis

Learn the who, the when and the what of treating deep...

Between additional available therapies, multiple new devices now on the market and evolving re­search supporting thrombus removal, Patrick Muck, MD, and Madhavi Meka, MD,...

Primary patency after venous stenting best in NIVL patients, study finds

A recent study concludes that non-thrombotic iliac vein lesion (NIVL) patients have better primary patency after venous stenting than patients with venous thrombotic disorders....

Study finds anatomic positioning and physical activity type can cause device...

A recent multicentre, prospective study has found that stent deformations are greater in the common iliac vein with higher levels of hip flexion, as...
mechanical thrombectomy

Mechanical thrombectomy for DVT: Randomized data needed to boost growing evidence...

Two datasets presented during the late-breaking clinical trials session at The VEINS (Venous Endovascular Interventional Strategies) 2022  (Oct. 30–31) in Las Vegas—the latest results...

Key differences in presentation, outcomes for distal versus proximal DVT uncovered

A new study highlights key differences in clinical features and comorbidities, as well as short-term and also long-term outcomes for patients with distal deep...

CLTI, VTE and post-thrombotic syndrome: Leading experts discuss crucial decision-making in...

This advertorial is sponsored by ACHL. For Anahita Dua, MBChB, the stark realities and complexities of peripheral arterial disease (PAD) patients undergoing endovascular treatment for...

AVF 2022: Six-month CLOUT data indicate ClotTriever can effectively remove full...

Six-month outcomes from the ongoing CLOUT registry demonstrate the “safety and efficacy” of the ClotTriever thrombectomy system in a real-world deep vein thrombosis (DVT)...

Registry data show greater clot chronicity on post-procedure inspection than initially...

Nearly half of patients deemed pre-procedurally to be suffering an acute case of deep vein thrombosis (DVT) turned out to have a “much more”...

Vetex Medical announces positive one-year outcomes for ReVene thrombectomy catheter

Vetex Medical has announced positive one-year outcomes from a European clinical study of the ReVene thrombectomy catheter. In patients with iliofemoral vein thrombus, the...

Dispatches from the vascular front: COVID-19 strikes New Jersey like ‘tidal...

Operating in the shadow of New York City, Clifford M. Sales, MD, has had his finger on the pulse of North America's two worst-affected...

VenaSeal superior for management of chronic venous insufficiency, finds systematic review

According to a network meta-analysis, the VenaSeal system by Medtronic is “a promising therapeutic option for anatomic success at six months.” The study, published...